RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 60 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2013. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,058,000 | +116.3% | 340,909 | +29.5% | 0.00% | +100.0% |
| Q2 2016 | $1,414,000 | +2.8% | 263,274 | -12.0% | 0.00% | 0.0% |
| Q1 2016 | $1,376,000 | -9.6% | 299,098 | +2.2% | 0.00% | 0.0% |
| Q4 2015 | $1,522,000 | -11.2% | 292,620 | +3.3% | 0.00% | -33.3% |
| Q3 2015 | $1,714,000 | -59.4% | 283,266 | +6.0% | 0.00% | -50.0% |
| Q2 2015 | $4,220,000 | +75.4% | 267,245 | +20.8% | 0.01% | +100.0% |
| Q1 2015 | $2,406,000 | +8.2% | 221,280 | +4.7% | 0.00% | 0.0% |
| Q4 2014 | $2,223,000 | +26.7% | 211,296 | +15.5% | 0.00% | 0.0% |
| Q3 2014 | $1,755,000 | -15.3% | 182,944 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $2,072,000 | +22.2% | 179,360 | +5.8% | 0.00% | 0.0% |
| Q1 2014 | $1,696,000 | -4.9% | 169,562 | +23.8% | 0.00% | 0.0% |
| Q4 2013 | $1,784,000 | -6.3% | 136,954 | +8.0% | 0.00% | -25.0% |
| Q3 2013 | $1,903,000 | +75.9% | 126,802 | +10.8% | 0.00% | +100.0% |
| Q2 2013 | $1,082,000 | – | 114,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |